Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 1 (2004), Issue 3 (October)

1. Correlation between the respiratory waveform measured using a respiratory sensor and 3D tumor motion in gated radiotherapy.
   Int J Radiat Oncol Biol Phys, 60(3): 951-8. [Abstract] [Full-text]
2. Monte Carlo simulations with time-dependent geometries to investigate effects of organ motion with high temporal resolution.
   Int J Radiat Oncol Biol Phys, 60(3): 942-50. [Abstract] [Full-text]
3. Measurement of lung tumor motion using respiration-correlated CT.
   Int J Radiat Oncol Biol Phys, 60(3): 933-41. [Abstract] [Full-text]
4. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer.
   Int J Radiat Oncol Biol Phys, 60(3): 759-66. [Abstract] [Full-text]
5. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer.
   Int J Radiat Oncol Biol Phys, 60(3): 748-58. [Abstract] [Full-text]
6. Improved local control with higher doses of radiation in large-volume stage III non-small-cell lung cancer.
   Int J Radiat Oncol Biol Phys, 60(3): 741-7. [Abstract] [Full-text]
7. Alteration of autoantibodies against p53 in Taiwanese lung cancer patients undergoing chemotherapy.
   Clin Chim Acta, 349(1): 87-96. [Abstract] [Full-text]
8. Bone resorption activity of osteolytic metastatic lung and breast cancers.
   J Orthop Res, 22(6): 1161-7. [Abstract] [Full-text]
9. Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer.
   Lung Cancer, 46(2): 255-61. [Abstract] [Full-text]
10. Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancer.
    Lung Cancer, 46(2): 247-54. [Abstract] [Full-text]
11. Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study.
    Lung Cancer, 46(2): 233-45. [Abstract] [Full-text]
12. The beneficial effects of specialist thoracic surgery on the resection rate for non-small-cell lung cancer.
    Lung Cancer, 46(2): 227-32. [Abstract] [Full-text]
13. Study design considerations in clinical outcome research of lung cancer using microarray analysis.
    Lung Cancer, 46(2): 215-26. [Abstract] [Full-text]
14. The significance of serum active matrix metalloproteinase-9 in patients with non-small cell lung cancer.
    Lung Cancer, 46(2): 205-13. [Abstract] [Full-text]
15. Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray study.
    Lung Cancer, 46(2): 197-204. [Abstract] [Full-text]
16. Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy.
    Lung Cancer, 46(2): 187-96. [Abstract] [Full-text]
17. Histone deacetylase 1 mRNA expression in lung cancer.
    Lung Cancer, 46(2): 171-8. [Abstract] [Full-text]
18. Gender difference in human papillomarvirus infection for non-small cell lung cancer in Taiwan.
    Lung Cancer, 46(2): 165-70. [Abstract] [Full-text]
19. Lung cancer mortality predictions for Ireland 2001-2015 and current trends in North Western Europe.
    Lung Cancer, 46(2): 157-63. [Abstract] [Full-text]
20. Role of epoetin in the management of anaemia in patients with lung cancer.
    Lung Cancer, 46(2): 149-56. [Abstract] [Full-text]
21. The biology of non-small-cell lung cancer: identifying new targets for rational therapy.
    Lung Cancer, 46(2): 135-48. [Abstract] [Full-text]
22. Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer.
    Am J Physiol Lung Cell Mol Physiol, 287(5): L981-91. [Abstract] [Full-text]
23. Oblique approach of computed tomography guided needle biopsy using multiplanar reconstruction image by multidetector-row CT in lung cancer.
    Eur J Radiol, 52(2): 206-11. [Abstract] [Full-text]
24. Dynamic MR imaging: value of differentiating subtypes of peripheral small adenocarcinoma of the lung.
    Eur J Radiol, 52(2): 144-50. [Abstract] [Full-text]
25. Absence of association with cancer risk and low frequency of alterations at a p53 responsive PIG3 gene polymorphism in breast and lung carcinomas.
    Mutat Res, 556(1): 143-50. [Abstract] [Full-text]
26. Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
    Anal Biochem, 334(2): 266-75. [Abstract] [Full-text]
27. Pesticides and lung cancer risk in the agricultural health study cohort.
    Am J Epidemiol, 160(9): 876-85. [Abstract] [Full-text]
28. Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice.
    Int J Cancer, 112(6): 994-1002. [Abstract] [Full-text]
29. Spontaneous regression of lung metastasis in the absence of tumor necrosis factor receptor p55.
    Int J Cancer, 112(6): 927-33. [Abstract] [Full-text]
30. JTE-522, a selective COX-2 inhibitor, interferes with the growth of lung metastases from colorectal cancer in rats due to inhibition of neovascularization: a vascular cast model study.
    Int J Cancer, 112(6): 920-6. [Abstract] [Full-text]
31. Treatment of small cell lung cancer.
    Crit Rev Oncol Hematol, 52(2): 117-26. [Abstract] [Full-text]
32. GSTP1 affects chemoresistance against camptothecin in human lung adenocarcinoma cells.
    Cancer Lett, 216(1): 89-102. [Abstract] [Full-text]
33. Prognostic analysis of pulmonary adenocarcinoma subclassification with special consideration of papillary and bronchioloalveolar types.
    Histopathology, 45(5): 468-76. [Abstract] [Full-text]
34. Pulmonary adenocarcinoma is associated with poor long-term survival after surgical resection. Effect of allogeneic blood transfusion.
    Cancer, 101(9): 2058-66. [Abstract] [Full-text]
35. Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species.
    J Thorac Cardiovasc Surg, 128(5): 740-8. [Abstract] [Full-text]
36. Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease.
    J Clin Oncol, 22(21): 4351-6. [Abstract] [Full-text]
37. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial.
    J Clin Oncol, 22(21): 4341-50. [Abstract] [Full-text]
38. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
    J Clin Oncol, 22(21): 4329-40. [Abstract] [Full-text]
39. Does increased cigarette consumption nullify any reduction in lung cancer risk associated with low-tar filter cigarettes?
    Inhal Toxicol, 16(13): 817-33. [Abstract] [Full-text]
40. Video-assisted thoracic surgery upper lobe trisegmentectomy for early-stage left apical lung cancer.
    Ann Thorac Surg, 78(5): 1858-60. [Abstract] [Full-text]
41. Alveolar adenoma.
    Ann Thorac Surg, 78(5): 1842-3. [Abstract] [Full-text]
42. Intrapleural hyperthermic perfusion with chemotherapy increases apoptosis in malignant pleuritis.
    Ann Thorac Surg, 78(5): 1769-72. [Abstract] [Full-text]
43. Feasibility and results of awake thoracoscopic resection of solitary pulmonary nodules.
    Ann Thorac Surg, 78(5): 1761-8. [Abstract] [Full-text]
44. Frozen section diagnoses of small pulmonary nodules: accuracy and clinical implications.
    Ann Thorac Surg, 78(5): 1755-9. [Abstract] [Full-text]
45. Arterial invasion predicts early mortality in stage I non-small cell lung cancer.
    Ann Thorac Surg, 78(5): 1748-53. [Abstract] [Full-text]
46. Personal experience in surgical management of pulmonary pleomorphic carcinoma.
    Ann Thorac Surg, 78(5): 1742-7. [Abstract] [Full-text]
47. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.
    Ann Thorac Surg, 78(5): 1734-41. [Abstract] [Full-text]
48. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.
    Ann Thorac Surg, 78(5): 1728-33. [Abstract] [Full-text]
49. Comparison of cancer survival in UK and Australia: rates are higher in Australia for three major sites.
    Br J Cancer, 91(9): 1663-5. [Abstract] [Full-text]
50. FISH cytogenetics and prognosis in breast and non-small cell lung cancers.
    Cytometry B Clin Cytom, 62(1): 52-6. [Abstract] [Full-text]
51. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
    Mol Carcinog, 41(4): 187-96. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.